Zacks Investment Research upgraded shares of Aspen Aerogels, Inc. (NYSE:ASPN) from a hold rating to a buy rating in a report released on Thursday morning. Zacks Investment Research currently has $5.50 target price on the construction company’s stock.
According to Zacks, “Aspen Aerogels, Inc. is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in large-scale energy infrastructure facilities. The Company offers insulation for high temperature steam pipes, vessels, and equipment. Aspen serves petrochemical, refinery, industrial, and power generation sectors. It manufactures Cryogel (R), Pyrogel (R) and Spaceloft (R) products. Aspen Aerogels, Inc. is headquartered in Northborough, Massachusetts. “
Separately, ValuEngine downgraded shares of Aspen Aerogels from a sell rating to a strong sell rating in a research report on Friday, July 28th.
Shares of Aspen Aerogels (NYSE ASPN) opened at $4.87 on Thursday. Aspen Aerogels has a one year low of $3.63 and a one year high of $4.97.
Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Thursday, November 2nd. The construction company reported ($0.13) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.14) by $0.01. The firm had revenue of $27.20 million during the quarter, compared to analyst estimates of $28.23 million. Aspen Aerogels had a negative net margin of 22.72% and a negative return on equity of 21.86%. The company’s revenue for the quarter was down 8.1% on a year-over-year basis. During the same quarter last year, the business posted ($0.13) EPS. equities research analysts expect that Aspen Aerogels will post -0.88 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Aspen Aerogels, Inc. (ASPN) Upgraded at Zacks Investment Research” was first reported by BBNS and is the sole property of of BBNS. If you are reading this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The correct version of this article can be viewed at https://baseballnewssource.com/markets/aspen-aerogels-inc-aspn-upgraded-at-zacks-investment-research/1769320.html.
Institutional investors have recently added to or reduced their stakes in the company. Oaktop Capital Management II L.P. bought a new position in Aspen Aerogels in the 2nd quarter worth approximately $5,434,000. Quantum Capital Management boosted its holdings in Aspen Aerogels by 1,552.9% in the 3rd quarter. Quantum Capital Management now owns 223,966 shares of the construction company’s stock worth $974,000 after buying an additional 210,416 shares during the period. Essex Investment Management Co. LLC bought a new position in Aspen Aerogels in the 3rd quarter worth approximately $823,000. Royce & Associates LP boosted its holdings in Aspen Aerogels by 41.6% in the 2nd quarter. Royce & Associates LP now owns 585,954 shares of the construction company’s stock worth $2,607,000 after buying an additional 172,030 shares during the period. Finally, Mesirow Financial Investment Management Inc. bought a new position in Aspen Aerogels in the 2nd quarter worth approximately $330,000. 76.08% of the stock is owned by hedge funds and other institutional investors.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aspen Aerogels Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels Inc. and related companies with our FREE daily email newsletter.